Your browser doesn't support javascript.
loading
Bromodomains: a new target class for drug development.
Cochran, Andrea G; Conery, Andrew R; Sims, Robert J.
Affiliation
  • Cochran AG; Department of Early Discovery Biochemistry, Genentech, South San Francisco, CA, USA. cochran.andrea@gene.com.
  • Conery AR; Constellation Pharmaceuticals, Cambridge, MA, USA. Andy.Conery@constellationpharma.com.
  • Sims RJ; Constellation Pharmaceuticals, Cambridge, MA, USA.
Nat Rev Drug Discov ; 18(8): 609-628, 2019 08.
Article in En | MEDLINE | ID: mdl-31273347
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Transcription Factors / Drug Development Type of study: Prognostic_studies Limits: Humans Language: En Journal: Nat Rev Drug Discov Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2019 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Transcription Factors / Drug Development Type of study: Prognostic_studies Limits: Humans Language: En Journal: Nat Rev Drug Discov Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2019 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido